A novel mithramycin analogue with high antitumor activity and less toxicity generated by combinatorial biosynthesis
Citación:Journal of medicinal chemistry, 55(12), p. 5813-5825, (2012); doi:10.1021/jm300234t
Descripción física:p. 5813-5825
This work was supported by grants from the National Institutes of Health (Grant CA091901 to J.R.) and the Spanish Ministry of Science and Innovation (Grants BIO2005-04115 and BIO2008-00269 to C.M. and Grant PET2005-0401 to C.M. and F.M.). M.P. was the recipient of a predoctoral fellowship from the Spanish Ministry of Science and Innovation. L.E.N. was the recipient of Torres-Quevedo Program Funding (Grant PTQ04-3-0487) from the Spanish Ministry of Science and Innovation. S.E.N. was partially supported by a graduate fellowship from the University of Kentucky graduate school.
- Artículos